CBC With Differential/Platelet; Comp. Metabolic Panel (14); Urinalysis, Complete; Lipid Panel;
Hemoglobin A1c; Prostate−Specific Ag, Serum
CBC With Differential/Platelet
WBC 5.1 x10E3/uL 4.0 − 10.5 01
RBC 4.66 x10E6/uL 4.14 − 5.80 01
Hemoglobin 11.9 Low g/dL 12.6 − 17.7 01
Hematocrit 38.4 % 37.5 − 51.0 01
MCV 82 fL 79 − 97 01
MCH 25.5 Low pg 26.6 − 33.0 01
MCHC 31.0 Low g/dL 31.5 − 35.7 01
RDW 18.1 High % 12.3 − 15.4 01
Platelets 402 x10E3/uL 140 − 415 01
Neutrophils 54 % 40 − 74 01
Lymphs 33 % 14 − 46 01
Monocytes 10 % 4 − 13 01
Eos 2 % 0 − 7 01
Basos 1 % 0 − 3 01
Neutrophils (Absolute) 2.8 x10E3/uL 1.8 − 7.8 01
Lymphs (Absolute) 1.7 x10E3/uL 0.7 − 4.5 01
Monocytes(Absolute) 0.5 x10E3/uL 0.1 − 1.0 01
Eos (Absolute) 0.1 x10E3/uL 0.0 − 0.4 01
Baso (Absolute) 0.1 x10E3/uL 0.0 − 0.2 01
Immature Granulocytes 0 % 0 − 2 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 − 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 79 mg/dL 65 − 99 01
BUN 14 mg/dL 6 − 24 01
Creatinine, Serum 0.97 mg/dL 0.76 − 1.27 01
eGFR If NonAfricn Am 87 mL/min/1.73 >59
eGFR If Africn Am 100 mL/min/1.73 >59
BUN/Creatinine Ratio 14 9 − 20
Sodium, Serum 136 mmol/L 134 − 144 01
Potassium, Serum 4.2 mmol/L 3.5 − 5.2 01
Chloride, Serum 102 mmol/L 97 − 108 01
Carbon Dioxide, Total 19 mmol/L 19 − 28 01
**Please note reference interval change**
Calcium, Serum 8.8 mg/dL 8.7 − 10.2 01
Protein, Total, Serum 6.7 g/dL 6.0 − 8.5 01
Albumin, Serum 4.4 g/dL 3.5 − 5.5 01
Globulin, Total 2.3 g/dL 1.5 − 4.5
A/G Ratio 1.9 1.1 − 2.5
Bilirubin, Total 0.5 mg/dL 0.0 − 1.2 01
Alkaline Phosphatase, S 45 IU/L 25 − 150 01
AST (SGOT) 23 IU/L 0 − 40 01
ALT (SGPT) 32 IU/L 0 − 44 01
Urinalysis, Complete
Urinalysis Gross Exam 01
Specific Gravity 1.016 1.005 − 1.030 01
pH 6.0 5.0 − 7.5 01
Urine−Color Yellow Yellow 01
Appearance Clear Clear 01
WBC Esterase Negative Negative 01
Protein Negative Negative/Trace 01
Glucose Negative Negative 01
Ketones Negative Negative 01
Occult Blood Negative Negative 01
Bilirubin Negative Negative 01
Urobilinogen,Semi−Qn 0.2 mg/dL 0.0 − 1.9 01
Nitrite, Urine Negative Negative 01
Microscopic follows if indicated. 01
Microscopic Examination
Microscopic Examination See below: 01
WBC 0−5 /hpf 0 − 5 01
RBC 0−3 /hpf 0 − 3 01
Epithelial Cells (non renal) 0−10 /hpf 0 − 10 01
Mucus Threads Present Not Estab. 01
Bacteria None seen None seen/Few 01
Lipid Panel
Cholesterol, Total 172 mg/dL 100 − 199 01
Triglycerides 50 mg/dL 0 − 149 01
HDL Cholesterol 67 mg/dL >39 01
Comment 01
According to ATP−III Guidelines, HDL−C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 10 mg/dL 5 − 40
LDL Cholesterol Calc 95 mg/dL 0 − 99
Hemoglobin A1c 5.7 High % 4.8 − 5.6 01
Increased risk for diabetes: 5.7 − 6.4
Diabetes: >6.4
Glycemic control for adults with diabetes: <7.0
Prostate−Specific Ag, Serum
Prostate Specific Ag, Serum 0.6 ng/mL 0.0 − 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.



this is two weeks after coming off of 1000mcg oral tren a day for 4 week and liv 52 1 tab every day